Cite
A pilot study on the safety and efficacy of neoadjuvant chemo‑adoptive immunotherapy for locally advanced rectal cancer.
MLA
Okazawa, Yu, et al. “A Pilot Study on the Safety and Efficacy of Neoadjuvant Chemo‑adoptive Immunotherapy for Locally Advanced Rectal Cancer.” Oncology Letters, vol. 27, no. 3, Mar. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.3892/ol.2024.14234.
APA
Okazawa, Y., Kamigaki, T., Sugimoto, K., Yamada, T., Yoshida, Y., Okada, S., Ibe, H., Oguma, E., Iwai, T., Matsuda, A., Yamada, T., Hasegawa, S., Goto, S., Takimoto, R., & Sakamoto, K. (2024). A pilot study on the safety and efficacy of neoadjuvant chemo‑adoptive immunotherapy for locally advanced rectal cancer. Oncology Letters, 27(3), N.PAG. https://doi.org/10.3892/ol.2024.14234
Chicago
Okazawa, Yu, Takashi Kamigaki, Kiichi Sugimoto, Takeshi Yamada, Yoichiro Yoshida, Sachiko Okada, Hiroshi Ibe, et al. 2024. “A Pilot Study on the Safety and Efficacy of Neoadjuvant Chemo‑adoptive Immunotherapy for Locally Advanced Rectal Cancer.” Oncology Letters 27 (3): N.PAG. doi:10.3892/ol.2024.14234.